Media OutReach
Sanofi sets Singapore Book of Records with the ‘Largest Mural of Magnetic Hands’ – a Public Pledge against Respiratory Syncytial Virus (RSV) in Nationwide Awareness Campaign
- Sanofi has achieved a new Singapore Book of Records milestone featuring more than 1,000 RSV awareness pledges.
- The Together Against RSV campaign unites families, healthcare partners and communities to spotlight the risks of RSV and its impact on all infants.
- Each magnetic hand symbolises a pledge of protection, creating an impactful visual reminder of the nation’s shared commitment to safeguarding young children’s health against RSV.
SINGAPORE – Media OutReach Newswire – 13 October 2025 – Sanofi has made history with a nationwide public health activation by clinching a spot in the Singapore Book of Records with the ‘Largest Mural of Magnetic Hands’, a public pledge against Respiratory Syncytial Virus (RSV) in its Together Against RSV campaign. The striking mural featured a total of over 1,000 hand pledges, each representing a parent, caregiver, or supporter who committed to raising awareness of Respiratory Syncytial Virus (RSV) – a common yet potentially serious virus – and protecting all infants from its risks.
Over the three-day event at Serangoon NEX, families, healthcare partners, and community members came together to symbolically place hand-shaped magnets on a panelled mural, with each hand carrying a personal pledge of commitment to learning about and fighting against RSV.
Zainab Sadat, Head of Vaccines, Sanofi Southeast Asia & India
“This record is more than just numbers; it is a symbol of unity and a testament to the collective power of Singaporean families, healthcare professionals, and communities coming together for a cause that truly matters. Through our ‘Together Against RSV’ campaign, we hope to spark ongoing conversations about RSV and empower parents with knowledge and preventive measures, including immunisation options, to protect their little ones. Together, we are building a future where every baby can breathe a little easier, and every family can rest a little more peacefully.”
The mural, measuring 2 meters tall by 5.1 meters wide, now serves as a striking visual reminder of the nation’s shared commitment to combating RSV. The event also complemented wider awareness initiatives, including collaborations with hospitals, parent communities, and an educational microsite (TogetherAgainstRSV.sg) in collaboration with the Singapore Paediatric Society, as part of Sanofi’s mission to empower parents with trusted information and preventive solutions.
Around the world, about two in three infants contract RSV before their first birthday1, making it the most common cause of lower respiratory tract infections, including bronchiolitis and pneumonia, in young children2. In Singapore, RSV is also a leading cause of infant hospitalisations, with the majority of cases occurring in otherwise healthy, full-term babies. Each year, an estimated 1,804 children under 29 months are hospitalised due to RSV-related illness3-7.
Hashtag: #Sanofi
The issuer is solely responsible for the content of this announcement.
About RSV
RSV is a highly contagious virus that can lead to serious respiratory illness for infants.2 It is a leading cause of hospitalisation in all infants, with most hospitalisations for RSV occurring in otherwise healthy infants born at term3-7. Two out of three infants are infected with RSV during their first year of life and almost all children are infected by their second birthday1. Globally, in 2019, there were approximately 33 million cases of acute lower respiratory infections leading to more than three million hospitalisations, and it was estimated that there were 26,300 in-hospital deaths of children younger than five years8. RSV-related direct medical costs, globally — including hospital, outpatient and follow-up care — were estimated at €4.82 billion in 20179.
About Sanofi
Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.
For more information, visit 
www.sanofi.com.
Sanofi Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi’s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that pandemics or other global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2022. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.
References
- Walsh, EE. Respiratory Syncytial Virus Infection: An Illness for All Ages. Clinics in Chest Medicine. 2017;38(1):29-36.
- Karron A. Respiratory Syncytial Virus Vaccines and Monoclonal antibodies. Orenstein W, Offit P, Edwards KM, Plotkin S. Plotkin’s Vaccines, eighth edition: 998-1004. Elsevier 2023.
- Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(5 Suppl):S127-S132. doi:10.1067/s00223476(03)00510-9.
- Zhou H, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012;54:1427–1436.
- Rha B, et al. Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020;146:e20193611.
- Arriola CS, et al. Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15. J Pediatric Infect Dis Soc. 2020;9:587-595
- Tam CC, et al. Burden and Cost of Hospitalization for Respiratory Syncytial Virus in Young Children, Singapore. Emerg Infect Dis. 2020 Jul;26(7):1489-1496
- Li Y, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 2022;399:92047–64.
- Zhang S, et al. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. J Infect Dis. 2020;222(Suppl 7):S680-687.
MAT-SG-2500364-1.0-10/202
This year’s forum is an important supporting event of the 18th Cross-Strait Forum. During the event, nine Fujian-Taiwan financial integration projects were signed, with a total value of RMB 9.1 billion. The projects cover a wide range of financial services across areas including cross-strait industrial cooperation, water supply security for public welfare, capacity upgrades for long-established Taiwan-funded enterprises, technology and innovation industries, and modern agriculture. These initiatives continue to unlock the benefits of financial policies, promote shared access to financial resources for Taiwan compatriots and Taiwan-funded enterprises, and inject new momentum into industrial integration between Fujian and Taiwan.
At the forum, the Cross-Strait Wealth and Asset Management Cross-Sector Alliance was officially inaugurated. Supported by Jinyuan Group and jointly proposed by its affiliated financial institutions, the alliance was co-founded by Xiamen International Trust, Jinyuan Uni-President Securities, Yuanxin Yongfeng Fund, Fubon Bank (China), Junlong Life Insurance, and Xiamen Chang Gung Hospital, among others. Centered on serving the wealth management and asset management needs of people on both sides of the Taiwan Strait, the alliance aims to build a one-stop service platform covering asset allocation for Taiwan compatriots and Taiwan-funded enterprises on the mainland, family trusts and wealth succession planning, pension finance, and healthcare protection solutions.
The forum also unveiled a series of innovative financial achievements related to Taiwan. The banking industry’s first group standard dedicated to Taiwan-related financial services on the mainland, the “Specification for Taiwan-Related Financial Services of Banking Financial Institutions,” was officially released. At the same time, the “Bailufen” Taiwan Compatriot Financial Service Platform was introduced, further enhancing financial services for Taiwan compatriots living in Fujian and supporting the development of Taiwan-funded enterprises.
Hashtag: #StraitsFinancialForum
The issuer is solely responsible for the content of this announcement.
Media OutReach
Verdant Rock Receives BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings
“The infrastructure and capital markets we are targeting have been systematically underserved over the past decade. Verdant Rock enters this space with an investment grade rating, a strong capital position, the regulatory standing, the technical capability, and the long-term commitment that issuers and their advisers have been unable to find elsewhere.”
— Tolga Uzuner, Co-Founder, Chief Executive Officer, Verdant Rock Limited
The Fitch Ratings report can be accessed here:
Fitch Rates Verdant Rock at ‘BBB+’; Outlook Stable
Verdant Rock’s Class 3B registration can be verified via the BMA’s register of regulated entities (search “Verdant Rock”): https://www.bma.bm/regulated-entities
Notes to editors: For the May 2026 licensing announcement, see https://bernews.com/2026/05/walkers-supports-verdant-rock-licensing/
This announcement is (i) for information only; (ii) not an offer or solicitation to buy or sell any security, insurance product, or financial guarantee; and (iii) not for distribution in any jurisdiction where to do so would be unlawful. Forward-looking statements are not guarantees of future results, and Verdant Rock undertakes no obligation to update them. A credit rating is not a recommendation to buy, sell or hold any security and may be subject to revision, suspension or withdrawal at any time by the assigning rating agency.
Hashtag: #VerdantRock
The issuer is solely responsible for the content of this announcement.
ABOUT VERDANT ROCK
Verdant Rock Limited is a Bermuda-based insurance company, regulated by the Bermuda Monetary Authority, providing Basel III and Solvency II compliant financial guarantees in emerging markets, designed to qualify as eligible credit protection under Basel and major insurance solvency regimes, for the benefit of institutions globally.
Online viewers praised the translation quality, with comments including “The quality of this real-time translation is amazing,” “The translation is incredibly fast,” and “The live speech recognition quality is surprisingly good.” Some viewers assumed the subtitles came from NVIDIA’s official translation team.
The achievement demonstrates how Taiwan’s media industry is adapting to AI-driven transformation. TVBS is positioning itself as a leader in integrating proprietary AI development with real-world broadcast applications. The company completed optimization and deployment of the system in just nine days — a process that traditionally requires months of dedicated training, according to Andy Yang, manager of TVBS AI Future Technology Department.
Yang explained that the biggest challenge in real-time translation lies in balancing “content accuracy” with “reading fluency” under extremely tight time constraints. Huang’s speaking style is highly improvisational and frequently switches between English, Mandarin and Taiwanese, while audience applause and cheering often occur simultaneously.
Applying standard off-the-shelf translation software in such an environment would likely result in sentence segmentation errors and unclear semantic interpretation, Yang said. Rather than pursuing “zero-latency” translation at all costs, TVBS designed a subtitle presentation mechanism specifically tailored to the keynote format.
Prior to the event, the TVBS team conducted extensive cross-platform testing on multiple AI translation models, evaluating latency and error rates. By introducing a carefully calibrated broadcast delay, the system gained additional time to process semantic meaning and contextual alignment. This approach enabled smoother subtitles matching natural Chinese reading habits, Yang said.
The team also built a dedicated knowledge base for NVIDIA GTC Taipei, compiling AI industry terminology, product names and technical keywords in advance. This significantly improved translation quality and the accuracy of professional content delivery. TVBS’s real-time translation system can be customized based on different broadcasting scenarios, Yang noted.
Yang emphasized that the key to the rapid nine-day deployment was cross-department collaboration. Engineering teams handled hardware tuning and signal integration, while internal technical and content teams managed ongoing model training and refinement. TVBS established a collaborative workflow integrating both technology and editorial expertise.
Through continuous iteration and adjustment, the team incorporated Taiwanese linguistic nuances and natural Chinese phrasing into the system. This enhanced fluency and readability beyond what generic AI models alone could achieve, ultimately shaping what Yang called a distinct “TVBS AI style.” The approach reflects the company’s “3T” philosophy — Truth, Trust and Technology.
In his keynote at the Taipei Music Center, Huang focused on AI infrastructure, next-generation computing platforms and NVIDIA’s latest technological roadmap. GTC Taipei 2026 attracted significant international attention as AI continues to reshape global industries. Through its own transformation journey, TVBS hopes to help lead Taiwan’s media industry into a new era shaped by AI.
Hashtag: #TVBS
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn